Satoh Nana, Yokoyama Chikako, Itamura Noriaki, Miyajima-Nakano Yoshiharu, Hisatomi Hisashi
Laboratory of Cellular and Molecular Biochemistry, Department of Materials and Life Science, Seikei Universty, Musashino, Tokyo 180-8633, Japan.
Oncol Lett. 2015 Jan;9(1):330-334. doi: 10.3892/ol.2014.2699. Epub 2014 Nov 11.
Mitochondrial succinate dehydrogenase (SDH) is localized to the inner mitochondrial membrane and is responsible for the redox of succinic acid. SDH is a tetrameric iron-sulfur flavoprotein of the tricarboxylic acid cycle and respiratory chain. The SDH complex, subunit C () transcript has deletion-type alternative splicing sites. Generally, alternative splicing produces variant proteins and expression patterns, as products of different genes. In certain cases, specific alternative splicing variants (ASVs) have been associated with human disease. Due to a frameshift mutation causing loss of the heme binding region, the Δ5 isoform (lacking exon 5) exhibits no SDHC activity. To investigate whether the splicing variants can function as dominant-negative inhibitors, ASVs were overexpressed in HCT-15 human colorectal cancer cells. Using real-time reverse transcription-polymerase chain reaction, a dominant-negative effect of the Δ5 isoform on mRNA was shown. In addition, Δ5 overexpression increased the levels of reactive oxygen species. Furthermore, in the Δ5 isoform-overexpressing cells, SDH activity was reduced. SDHC activation is a significant event during the electron transport chain, and the function of the Δ5 variant may be significant for the differentiation of tumor cells.
线粒体琥珀酸脱氢酶(SDH)定位于线粒体内膜,负责琥珀酸的氧化还原反应。SDH是三羧酸循环和呼吸链中的一种四聚体铁硫黄素蛋白。SDH复合体亚基C()转录本具有缺失型可变剪接位点。一般来说,可变剪接会产生不同的蛋白质和表达模式,就如同不同基因的产物一样。在某些情况下,特定的可变剪接变体(ASV)与人类疾病有关。由于移码突变导致血红素结合区域缺失,Δ5异构体(缺少外显子5)不具有SDHC活性。为了研究这些剪接变体是否能作为显性负性抑制剂发挥作用,在HCT-15人结肠癌细胞中过表达了ASV。通过实时逆转录-聚合酶链反应,显示了Δ5异构体对mRNA的显性负性作用。此外,Δ5的过表达增加了活性氧的水平。此外,在过表达Δ5异构体的细胞中,SDH活性降低。SDHC的激活是电子传递链中的一个重要事件,Δ5变体的功能可能对肿瘤细胞的分化具有重要意义。